These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7534777)

  • 1. Prolonged occlusion in the treatment of psoriasis: a clinical and immunohistologic study.
    Griffiths CE; Tranfaglia MG; Kang S
    J Am Acad Dermatol; 1995 Apr; 32(4):618-22. PubMed ID: 7534777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative study of calcipotriene (MC 903) ointment and fluocinonide ointment in the treatment of psoriasis.
    Bruce S; Epinette WW; Funicella T; Ison A; Jones EL; Loss R; McPhee ME; Whitmore C
    J Am Acad Dermatol; 1994 Nov; 31(5 Pt 1):755-9. PubMed ID: 7929921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The efficacy of three class I topical synthetic corticosteroids, fluocinonide 0.1% cream, clobetasol 0.05% cream and halobetasol 0.05% cream: a Scholtz-Dumas bioassay comparison.
    Lee CS; Koo J
    J Drugs Dermatol; 2009 Aug; 8(8):751-5. PubMed ID: 19663113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Once-daily tazarotene gel versus twice-daily fluocinonide cream in the treatment of plaque psoriasis.
    Lebwohl M; Ast E; Callen JP; Cullen SI; Hong SR; Kulp-Shorten CL; Lowe NJ; Phillips TJ; Rosen T; Wolf DI; Quell JM; Sefton J; Lue JC; Gibson JR; Chandraratna RA
    J Am Acad Dermatol; 1998 May; 38(5 Pt 1):705-11. PubMed ID: 9591815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of amcinonide ointment 0.1 percent twice daily and fluocinonide ointment 0.05 percent three times daily in the treatment of psoriasis.
    Cornell RC
    Cutis; 1983 May; 31(5):566-9. PubMed ID: 6851655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of 0.25% desoxymethasone ointment with 0.05% fluocinonide ointment in psoriasis.
    Kuokkanen K
    Curr Med Res Opin; 1976-1977; 4(10):703-5. PubMed ID: 800971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of topical fluocinonide ointment on phototherapy of psoriasis.
    LeVine MJ; Parrish JA
    J Invest Dermatol; 1982 Feb; 78(2):157-9. PubMed ID: 7057051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of refractory psoriasis with fluocinonide gel.
    Willoughby CB; Cook WR
    Cutis; 1977 Jul; 20(1):144-5. PubMed ID: 884957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psoriasis: topical corticosteroid therapy.
    Lynfield Y; Watsky M
    Cutis; 1976 Jul; 18(1):133, 136-7. PubMed ID: 797547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of psoriasis with amcinonide 0.1 percent and fluocinonide 0.05 percent ointments. A comparative double-blind study.
    Engel MF
    Cutis; 1982 Jun; 29(6):646-50. PubMed ID: 7049592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative study of desoximetasone ointment 0.25% versus fluocinonide ointment 0.05% in patients with psoriasis.
    Clin Ther; 1985; 8(1):118-25. PubMed ID: 3914368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Case report: Fluocinonide-induced perioral dermatitis in a patient with psoriasis.
    Kosari P; Feldman SR
    Dermatol Online J; 2009 Mar; 15(3):15. PubMed ID: 19379659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multicenter study comparing 0.05% gel formulations of desoximetasone and fluocinonide in patients with scalp psoriasis.
    Willis I; Cornell RC; Penneys NS; Zaias N
    Clin Ther; 1986; 8(3):275-82. PubMed ID: 3521856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of psoriasis with topically applied tretinoin and steroid ointment.
    Kaidbey KH; Petrozzi JW; Kligman AM
    Arch Dermatol; 1975 Aug; 111(8):1001-3. PubMed ID: 786170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of the Betamethasone valerate 0.1% plaster in mild-to-moderate chronic plaque psoriasis: a randomized, parallel-group, active-controlled, phase III study.
    Naldi L; Yawalkar N; Kaszuba A; Ortonne JP; Morelli P; Rovati S; Mautone G
    Am J Clin Dermatol; 2011 Jun; 12(3):191-201. PubMed ID: 21284407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psoriasis therapy: comparative studies with a hydrocolloid dressing, plastic film occlusion, and triamcinolone acetonide cream.
    David M; Lowe NJ
    J Am Acad Dermatol; 1989 Sep; 21(3 Pt 1):511-4. PubMed ID: 2778112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of FK 506 on T lymphocytes, Langerhans' cells and the expression of cytokine receptors and adhesion molecules in psoriatic skin lesions: a preliminary study.
    Thomson AW; Nalesnik M; Abu-Elmagd K; Starzl TE
    Transplant Proc; 1991 Dec; 23(6):3330-1. PubMed ID: 1721452
    [No Abstract]   [Full Text] [Related]  

  • 18. Double-blind comparison of a dithranol and steroid mixture with a conventional dithranol regimen for chronic psoriasis.
    Grattan CE; Christopher AP; Robinson M; Cowan MA
    Br J Dermatol; 1988 Nov; 119(5):623-6. PubMed ID: 3061441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Remission and relapse of chronic plaque psoriasis treated once a week with clobetasol propionate occluded with a hydrocolloid dressing versus twice daily treatment with clobetasol propionate alone.
    Volden G; Kragballe K; Van De Kerkhof PC; Aberg K; White RJ
    J Dermatolog Treat; 2001 Sep; 12(3):141-4. PubMed ID: 12243704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Weekly treatment of psoriasis with a hydrocolloid dressing in combination with triamcinolone acetonide. A controlled comparative study.
    van de Kerkhof PC; Chang A; van der Walle HB; van Vlijmen-Willems I; Boezeman JB; Huigen-Tijdink R
    Acta Derm Venereol; 1994 Mar; 74(2):143-6. PubMed ID: 7911624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.